|
Nov 7
|
OPKO Health (OPK) Q3 Earnings Lag Estimates, Revenues Top
|
|
Nov 7
|
OPKO Health, Inc. (NASDAQ:OPK) Q3 2023 Earnings Call Transcript
|
|
Nov 7
|
BioReference® Signs On as the First Laboratory to Use MSK-ACCESS® Powered with SOPHiA DDM™
|
|
Nov 7
|
Opko Health (OPK) Q3 2023 Earnings Call Transcript
|
|
Nov 7
|
OPKO Health (OPK) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
|
|
Sep 29
|
OPKO Health Inc (OPK): A Deep Dive into Its Performance Potential
|
|
Sep 28
|
OPKO Health (OPK) - A Fairly Valued Stock with Room for Growth?
|
|
Sep 28
|
ModeX Therapeutics Secures BARDA Contract to Develop Novel Multispecific Antibodies Against Viral Infectious Disease Threats
|